Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma.

Abstract

This result indicates that promoter methylation present in the tumors of esophageal SCC patients can be detected in the serum of the same patient and that this approach can potentially be used for the screening and monitoring of the disease.